Chemically-Induced Peptic Ulcer: Gastroprotective Effects of Peach Fruit
Journal Title: Current Trends in Gastroenterology and Hepatology - Year 2018, Vol 1, Issue 2
Abstract
Background: Peptic ulcer, an inflammatory breach in the gastric and duodenal mucosa, is caused by hyper secretion of gastric acid and defective mucosal protective elements, affecting approximately 4 million people each year. The currently available antiulcer drugs are reported to have severe side effects. Hence, there is a need to develop more effective and less toxic alternative therapeutic agents from natural sources. The current study was conducted to investigate the therapeutic potential of Prunus persica Linn. Batsch fruit (Peach) against chemically-induced gastric and duodenal ulcers. Material and Methodology: 70% aqueous methanolic crude extract of Prunus persica (Pp.Cr) was prepared. Gastroprotective effects were evaluated by oral administration of Pp.Cr at the doses of 100, 300, 500 mg/kg for ten days. Normal control and intoxicated groups were treated with distilled water. Bismuth subsalicylate (88 mg/kg) was administered to the standard control group. On 10th day, all animals were intoxicated with ethanol (5 ml/kg) except normal control group, and one hour after intoxication, all animals were sacrificed, stomach isolated; and pH and acidity of gastric contents, ulcer index and percentage protection were calculated. One stomach from each group was analyzed histo pathologically. Duodenal protective effects were assessed by administering Pp.Cr (100, 300, 500 mg/kg) for fourteen days. The standard control group was treated with cimetidine (100 mg/kg). On 14th day, cysteamine (600 mg/kg) was administered in two divided doses at an interval of four hours to experimental animals to induce duodenal ulcer. All animals were dissected out 48 hours after the administration of first dose of cysteamine. Duodenum was isolated and analyzed for severity score. Histopathological examination of one duodenum from each group was performed. Results: In gastric ulcer model, Pp.Cr was found to increase pH and decrease the total acidity of gastric contents, and decrease the ulcer index, in dose-dependent manner at the doses of 100, 300 and 500 mg/kg. In duodenal ulcer model, Pp.Cr was observed to decrease the severity score and ulcer index, again in dose-dependent manner. Conclusion: The results of current study demonstrate the gastric and duodenal protective effects of the crude extract of Prunus persica (Pp.Cr), corroborating their folkloric use in the prevention and treatment of peptic ulcer.
Authors and Affiliations
Qaiser Jabeen, Sidra Arif, Fayyaz Anjum
Keywords
Related Articles
- EP ID EP569034
- DOI 10.32474/CTGH.2018.01.000107
- Views 87
- Downloads 0
Asymptomatic Portal Cavernoma Revealing Activated Protein C Resistance
Introduction: Unlike the child, the portal cavernoma (PC) remains an exceptional and unusual complication of portal thrombosis in adults and the elderly. We report an original observation of asymptomatic PC secondary to...
New Possibilities of Diagnostics of Non-Alcoholic Fatty Liver Disease
The aim of the study was to create a non-invasive model for diagnosing fibrosis and steatosis in non-alcoholic fatty liver disease. Materials and methods. The study included 183 patients with liver steatosis according to...
Utilization of Traditional Anticoagulation for Venous Thromboembolism in Patients with Liver Cirrhosis: Is It Safe?
Patients with liver cirrhosis are known to have increased risk bleeding particularly from gastrointestinal tract. However, recent literature has shown that patients with liver cirrhosis are also at increased risk of deve...
Assessment of the Depression‐level effectiveness of the Curse Words in Young Adults in Private Co-Educational Pharmaceutical Instituions in Pune University, India: A Preplanned, Causal‐Pathway‐Based Analysis
Depression and substance abuse is on the increase all over the world. The poor and the rich are also involved in this dangerous habit has impact not only on reproductive health but also has impact on family, society, inc...
Advanced Hepatocellular Carcinoma in A Scottish Population – Current Experience and the Future
Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current...